ODIN's online matchmaking series

This series is an opportunity to hear short pitches from people who have posted ideas, challenges, or resources in the ODIN Marketplace as part of the 2026 matchmaking stage.

The events (held on May 27 & 28) are open to researchers, clinicians, companies, and any other potential partners interested in exploring collaborations for the ODIN 2026 grant call. Participants can listen to pitches, ask questions, discover relevant expertise and resources, and connect with others who are interested in co-developing open, precompetitive research projects.

We have a full line-up of pitches planned over three sessions (see below). Sign up to take part and explore potential project collaborations.

Note: Click 'Event Website' to sign up (NOT 'add to calendar')

Info about event

Time

Wednesday 27 May 2026, at 09:00 - Thursday 28 May 2026, at 11:00

Add to calendar

Event website

By Chantelle Dana Driever

ODIN Pitch Day – click here to sign up by 26 May to receive a calendar invitation

Join the events directly by clicking here.

	Session 1	Session 2	Session 3
Date/Time	27 May, 9:00 – 11:00	27 May, 13:00 – 15:00	28 May, 9:00 – 11:00
Main Themes	Cardiovascular & Cardiometabolic Diseases (CVD/CMD); Disease-agnostic platforms/tools/methods; Regenerative Medicine (Regen Med)	Central Nervous System Diseases (CNS); Disease-agnostic platforms/ tools/methods; Infectious Diseases	Disease-agnostic platforms/tools/methods; Infectious Diseases

Full Lineup (Subject to Change):
SESSION	Name	Pitch Title (click link for more information on WorldLabs)	Primary Scientific Scope Area or Interest	Secondary Scientific Scope Areas
1	Jan Dominik Kampmann	OPtimising Troponin Interpretation and Use AMong Individuals with Reduced Kidney Function	CVD/CMD
1	Mark Denham	Stem Cell Organoid Platform for Investigating Neural Pathways Involved in Addiction and Obesity	CVD/CMD	CNS;
1	Kristian Kragholm	Wearable Biomarkers for Better CVD Risk Stratification and Diagnostics (the ORBIT-CVD project)	CVD/CMD	Agnostic platform/tool/method;
1	Dmitry Postnov	Multi-Modal Optical Imaging Platform for In Vivo Microvascular Studies in Mice	CVD/CMD	Agnostic platform/tool/method; CNS;
1	Dmitry Postnov	Optical Imaging Platform for Non-Invasive Microvascular Assessment in Humans	Agnostic platform/tool/method	CVD/CMD;
1	Stinne Geisen	Bridging human fibrosis models for biomarker discovery and therapeutic testing (Bifröst)	Regen med
1	Kristoffer Vitting-Seerup	Add isoform-level analysis to your project	Agnostic platform/tool/method	Broad scope relevance
1	Xavier Bofill De Ros	Functional characterization of Small RNA Therapeutics	Agnostic platform/tool/method
1	Christian Erikstrup	Danish Blood Donor Study Biobank	Agnostic platform/tool/method	CVD/CMD; Infectious Dis; CNS;
1	Peter Sørensen	Development of Machine Learning Methods for Enhanced Data Sharing and Prediction in Healthcare	Agnostic platform/tool/method	CVD/CMD; Infectious Dis; CNS;
2	Priyanka singh	Hybrid green AgNPs–MOF Surfaces for Prevention of AMR-Associated Biofilm Infections	Infectious Dis
2	Ling Ding	Siderophre inhibitors as novel antifungal targets	Infectious Dis
2	Anders Bundgård Sørensen	Agnostic metagenomics platform detecting microbial cell-free DNA for pathogen ID	Agnostic platform/tool/method	Infectious Dis; CVD/CMD;
2	Nigel Caterer	PANDA: a novel omics-based discovery platform for unbiased biomarker discovery	Agnostic platform/tool/method	CVD/CMD;CNS;
2	Rasmus Hartmann-Petersen	Massively parallel experimental & computational platforms for reactivating disease variants	CNS	Agnostic platform/tool/method;
2	Torben Moos	Optimizing CNS Therapeutics for Blood–Brain Barrier Delivery	CNS	Agnostic platform/tool/method;
2	Navneet Vasistha	Restoring sleep to improve cognition in brain disorders	CNS	Agnostic platform/tool/method;
2	Tingting Wang	Can Neurodevelopmental Disorders Be Prevented Before Birth? Toward a Precision Prevention Platform	CNS	Agnostic platform/tool/method;
2	Thomas Durcan	The Neuro's Early Drug Discovery: Moving from a target to a therapy through iPSC-derived CNS models	CNS	Agnostic platform/tool/method;
¨2	Nasrin Asgari	MYBRAINS—MYelin Boosting Brain Resilience and Inhibiting Neurological Sickness	CND
3	Søren Blikdal Hansen	Personalized Epigenomics for Translational Medical Research	Agnostic platform/tool/method	CVD/CMD;Infectious Dis;CNS;Regen Med;
3	Martin Frandsen	Avidity-Driven Monolabeling of Proteins	Agnostic platform/tool/method
3	Edwin Hwu	The Skin-Body Axis: Systemic Disease Detection via Skin Nanotexture.	CMD/CVD	Infectious, CNS, Disease-agnostic
3	Annette Bauer-Brandl	EXCAVATE: Can failure/delays of promising drug candidates be avoided?	Broad scope relevance	Agnostic platform/tool/method;
3	Massimo De Vittorio	Rapid CNS Infection & Drug Monitoring Platform	CNS	Infectious Dis;
3	Nina Molin Høyland-Kroghsbo	Phage engineering - for enhanced therapeutic effect	Infectious Dis	CVD/CMD;Regen Med;Agnostic platform/tool/method;CNS;
3	Klaus Eyer	Forward-Compatible Antibody Discovery via Integrated Repertoire Sequencing and Viral Evolution Model	Infectious Dis	Agnostic platform/tool/method;
3	Nick Volet	Far-UVC Evidence for Infection Control	Infectious Dis	Agnostic platform/tool/method;
3	Anne-Mette Lebech	BRAIN-BRIDGE: Breaching the barrier on brain inflammation. Transitioning CNS diagnostics to blood.	Infectious Dis